These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 14573829)

  • 1. Sensitivity requirements for the point of care diagnosis of Chlamydia trachomatis and Neisseria gonorrhoeae in women.
    Vickerman P; Watts C; Alary M; Mabey D; Peeling RW
    Sex Transm Infect; 2003 Oct; 79(5):363-7. PubMed ID: 14573829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An early evaluation of clinical and economic costs and benefits of implementing point of care NAAT tests for Chlamydia trachomatis and Neisseria gonorrhoea in genitourinary medicine clinics in England.
    Turner KM; Round J; Horner P; Macleod J; Goldenberg S; Deol A; Adams EJ
    Sex Transm Infect; 2014 Mar; 90(2):104-11. PubMed ID: 24273127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modelling the cost effectiveness of rapid point of care diagnostic tests for the control of HIV and other sexually transmitted infections among female sex workers.
    Vickerman P; Watts C; Peeling RW; Mabey D; Alary M
    Sex Transm Infect; 2006 Oct; 82(5):403-12. PubMed ID: 17012515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Syndromic versus laboratory-based diagnosis of cervical infections among female sex workers in Benin: implications of nonattendance for return visits.
    Mukenge-Tshibaka L; Alary M; Lowndes CM; Van Dyck E; Guédou A; Geraldo N; Anagonou S; Lafia E; Joly JR
    Sex Transm Dis; 2002 Jun; 29(6):324-30. PubMed ID: 12035021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening tests to detect Chlamydia trachomatis and Neisseria gonorrhoeae infections--2002.
    Johnson RE; Newhall WJ; Papp JR; Knapp JS; Black CM; Gift TL; Steece R; Markowitz LE; Devine OJ; Walsh CM; Wang S; Gunter DC; Irwin KL; DeLisle S; Berman SM
    MMWR Recomm Rep; 2002 Oct; 51(RR-15):1-38; quiz CE1-4. PubMed ID: 12418541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The performance of non-NAAT point-of-care (POC) tests and rapid NAAT tests for chlamydia and gonorrhoea infections. An assessment of currently available assays.
    Brook G
    Sex Transm Infect; 2015 Dec; 91(8):539-44. PubMed ID: 25935930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alarmingly poor performance in Chlamydia trachomatis point-of-care testing.
    van Dommelen L; van Tiel FH; Ouburg S; Brouwers EE; Terporten PH; Savelkoul PH; Morré SA; Bruggeman CA; Hoebe CJ
    Sex Transm Infect; 2010 Oct; 86(5):355-9. PubMed ID: 20876754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the Performance of a Point-of-Care Test for Chlamydia and Gonorrhea.
    Van Der Pol B; Taylor SN; Mena L; Lebed J; McNeil CJ; Crane L; Ermel A; Sukhija-Cohen A; Gaydos CA
    JAMA Netw Open; 2020 May; 3(5):e204819. PubMed ID: 32407506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multiplex PCR assay for the simultaneous detection of Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis.
    Abou Tayoun AN; Burchard PR; Caliendo AM; Scherer A; Tsongalis GJ
    Exp Mol Pathol; 2015 Apr; 98(2):214-8. PubMed ID: 25595915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potential impact of new generation molecular point-of-care tests on gonorrhoea and chlamydia in a setting of high endemic prevalence.
    Hui BB; Wilson DP; Ward JS; Guy RJ; Kaldor JM; Law MG; Hocking JS; Regan DG
    Sex Health; 2013 Aug; 10(4):348-56. PubMed ID: 23806149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High performance and acceptability of self-collected rectal swabs for diagnosis of Chlamydia trachomatis and Neisseria gonorrhoeae in men who have sex with men and women.
    van der Helm JJ; Hoebe CJ; van Rooijen MS; Brouwers EE; Fennema HS; Thiesbrummel HF; Dukers-Muijrers NH
    Sex Transm Dis; 2009 Aug; 36(8):493-7. PubMed ID: 19617869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A profile of the binx health
    Van Der Pol B; Gaydos CA
    Expert Rev Mol Diagn; 2021 Sep; 21(9):861-868. PubMed ID: 34225553
    [No Abstract]   [Full Text] [Related]  

  • 13. Identifying a consensus sample type to test for Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium, Trichomonas vaginalis and human papillomavirus.
    Coorevits L; Traen A; Bingé L; Van Dorpe J; Praet M; Boelens J; Padalko E
    Clin Microbiol Infect; 2018 Dec; 24(12):1328-1332. PubMed ID: 29559392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Point-of-care testing for chlamydia and gonorrhoea: implications for clinical practice.
    Natoli L; Maher L; Shephard M; Hengel B; Tangey A; Badman SG; Ward J; Guy RJ;
    PLoS One; 2014; 9(6):e100518. PubMed ID: 24956111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Public health implications of molecular point-of-care testing for chlamydia and gonorrhoea in remote primary care services in Australia: a qualitative study.
    Natoli L; Guy RJ; Shephard M; Whiley D; Tabrizi SN; Ward J; Regan DG; Badman SG; Anderson DA; Kaldor J; Maher L;
    BMJ Open; 2015 Apr; 5(4):e006922. PubMed ID: 25922100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. African women recently infected with HIV-1 and HSV-2 have increased risk of acquiring Neisseria gonorrhoeae and Chlamydia trachomatis in the Methods for Improving Reproductive Health in Africa trial.
    Venkatesh KK; van der Straten A; Mayer KH; Blanchard K; Ramjee G; Lurie MN; Chipato T; Padian NS; de Bruyn G
    Sex Transm Dis; 2011 Jun; 38(6):562-70. PubMed ID: 21278624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk scores to detect cervical infections in urban antenatal clinic attenders in Mwanza, Tanzania.
    Mayaud P; Uledi E; Cornelissen J; ka-Gina G; Todd J; Rwakatare M; West B; Kopwe L; Manoko D; Grosskurth H; Hayes R; Mabey D
    Sex Transm Infect; 1998 Jun; 74 Suppl 1():S139-46. PubMed ID: 10023365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Systematic Review of Point of Care Testing for Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis.
    Herbst de Cortina S; Bristow CC; Joseph Davey D; Klausner JD
    Infect Dis Obstet Gynecol; 2016; 2016():4386127. PubMed ID: 27313440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk-based screening for Chlamydia trachomatis and Neisseria gonorrhoeae prior to intrauterine device insertion.
    Grentzer JM; Peipert JF; Zhao Q; McNicholas C; Secura GM; Madden T
    Contraception; 2015 Oct; 92(4):313-8. PubMed ID: 26093189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comprehensive overview of urogenital, anorectal and oropharyngeal Neisseria gonorrhoeae testing and diagnoses among different STI care providers: a cross-sectional study.
    den Heijer CDJ; Hoebe CJPA; van Liere GAFS; van Bergen JEAM; Cals JWL; Stals FS; Dukers-Muijrers NHTM
    BMC Infect Dis; 2017 Apr; 17(1):290. PubMed ID: 28427377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.